Boston (Feb. 21, 2012) -- Mark E. Sobel, MD, Ph.D., Executive Officer of the American Society for Investigative Pathology (ASIP) has announced that Dr. Patricia A. D’Amore of the Mass. Eye and Ear Schepens Research Institute, is the recipient of the 2012 ASIP Rous-Whipple Award.
Dr. D’Amore will present her award lecture, “The Many Roles of VEGF in the Adult,” on Sunday, April 22, 2012 at the ASIP Annual Meeting at Experimental Biology 2012 in San Diego, CA. She will receive the Rous-Whipple Award on Monday, April 23, 2012 during the ASIP Awards Presentation and Membership Business Meeting. D'Amore's lecture will form the basis of a publication in The American Journal of Pathology.
The ASIP Rous Whipple Award is presented to a senior scientist with a distinguished career in research who has advanced the understanding of disease and has continued productivity at the time of this award.
Dr. D'Amore is the Co-Director of Research, Senior Scientist, & Ankeny Scholar of Retinal Molecular Biology, at the Mass. Eye and Ear Schepens Eye Research Institute, and Professor of Ophthalmology and Pathology at Harvard Medical School.
Dr. D'Amore's research focuses on vascular growth and development, with an emphasis on blood-vessel growth in the retina. Work conducted in her laboratory, and in collaboration with investigators at Mass Eye and Ear, formed the basis for the current use of anti-angiogenic therapies for diabetic retinopathy.
The American Society for Investigative Pathology (ASIP) is a society of biomedical scientists who investigate the mechanisms of disease. Investigative pathology is an integrative discipline that links the presentation of disease in the whole organism to its fundamental cellular and molecular mechanisms. It uses a variety of structural, functional, and genetic techniques and ultimately applies research findings to the diagnosis and treatment of diseases. ASIP is a member of the Federation of American Societies for Experimental Biology (FASEB), a coalition of 24 independent societies that plays an active role in lobbying for the interests of 100,000 biomedical scientists.
About Mass. Eye and Ear
Founded in 1824, Massachusetts Eye and Ear Infirmary is an independent specialty hospital providing patient care for disorders of the eye, ear, nose, throat, head and neck. Mass. Eye and Ear is an international leader in Ophthalmology and Otolaryngology research and a teaching partner of Harvard Medical School. Under the direction of Mass. Eye and Ear’s board of directors, the Massachusetts Eye and Ear Infirmary and Schepens Eye Research Institute recently formed the world’s largest and most robust private basic and clinical ophthalmology research enterprise. For more information, call 617-523-7900 or visit http://www.masseyeandear.org/.
Dr. David Jung, a board-certified member of Mass. Eye and Ear’s Otology Division, became interested in medicine early in life. Dr. Jung explains, “My father is an ENT (ear, nose, throat) specialist, so I was introduced to the medical field when I was very young.
You can make a difference! Take a moment to learn more about how you can help Mass. Eye and Ear improve the lives of people with vision, hearing, voice and balance problems. Find out how you can support all the great work at Mass. Eye and Ear.